Clinical Research Office
Serving as the clinical coordinating center for all activities related to clinical cancer research at UT Southwestern.
The Clinical Research Office (CRO) at UT Southwestern Medical Center's Harold C. Simmons Cancer Center provides support to researchers conducting research on possible new medications and treatments for cancer as well as new cancer prevention options.
Under the direction of principal investigators and disease team leaders, CRO study coordinators are responsible for finding, recruiting, and enrolling appropriate patients for clinical trials as well as educating patients about clinical trial options. They also ensure that the patients on study complete all necessary tests and follow-up visits as required for the trial.
The CRO also provides support for investigators through our regulatory staff, who oversee the appropriate submissions to the Protocol Review and Monitoring Committee (PRMC) and then the Institutional Review Board (IRB).
The PRMC is a Cancer Center committee that is responsible for reviewing all cancer-related clinical trials for scientific merit; monitoring progress of all approved protocols; and for closing protocols based upon poor accrual. All cancer-related protocols at UT Southwestern must be approved by the PRMC prior to submission the Institutional Review Board (IRB).
UT Southwestern has rigorous safeguards and other processes in place to protect patient safety and patient rights. An Institutional Review Board (IRB) oversees the medical research at our health care facilities, including UT Southwestern, Children's Medical Center Dallas, Parkland Health & Hospital System, UT Southwestern University Hospitals, and our affiliated clinical practices.
Questions regarding cancer clinical research at the Simmons Cancer Center and its affiliated hospitals, clinics, and diagnostic facilities may be directed to this office by calling 214-648-7097, or 214-645-HOPE (4673).